Molecule intelOpportunity: StrongEssentialCrowded market

Metoclopramide

103 brands · 62 companies · product forms

ATC: A03FA01 1 DRAP alert

Opportunity snapshot

Launch attractiveness
51
Market saturation
91
Price room
100
Regulatory risk
50
103
brands
62
companies
Rs 251.81
median price
90
price points
159.13x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 4%

Price room

Across observed sources and strengths
CheapestRs 20.89
MedianRs 251.81
Most expensiveRs 3,324.14
Spread159.13×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 159.13x across 90 trusted points (Rs 20.89-3324.14). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Metoclopramide — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2025-11-20
113. Recall Alert (Class-I) – Substandard Drug Products (Human)

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(9) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

62 canonical companies and 103 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 159.13x across 90 trusted points (Rs 20.89-3324.14). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2025-11-20 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.